Frequency and irregularity of heart rate in drivers suspected of driving under the influence of cannabis

European Journal of Internal Medicine

Volumn 19, Issue 8, 2008, Pages 608-612

  Khiabani, Hassan Z ^a   Mørland, Jørg ^a   Bramness, Jørgen G ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Cannabis; Irregularity of heart rate; Tachycardia

Indexed keywords

ALCOHOL; CANNABIS; DRONABINOL; NARCOTIC AGENT;

ADULT; ARTICLE; BLOOD SAMPLING; CANNABIS ADDICTION; CONTROLLED STUDY; DATA BASE; DRIVER; DRIVING ABILITY; FEMALE; HEART BEAT; HEART RATE; HEART RATE VARIABILITY; HERBAL MEDICINE; HUMAN; MAJOR CLINICAL STUDY; MALE; PUBLIC HEALTH; PULSE RATE; TACHYCARDIA;

ADULT; AUTOMOBILE DRIVING; CANNABIS; CASE-CONTROL STUDIES; FEMALE; HALLUCINOGENS; HEART RATE; HUMANS; MALE; SUBSTANCE ABUSE DETECTION; TACHYCARDIA; TETRAHYDROCANNABINOL;

EID: 56949084769     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2007.06.031     Document Type: Article

References (31)

1. Petronis K.R., and Anthony J.C. An epidemiologic investigation of marijuana- and cocaine-related palpitations. Drug Alcohol Depend 23 (1989) 219-226
2. Johnson S., and Domino E.F. Some cardiovascular effects of marihuana smoking in normal volunteers. Clin Pharmacol Ther 12 (1971) 762-768
3. Sidney S. Cardiovascular consequences of marijuana use. J Clin Pharmacol 42 (2002) 64S-70S
4. Fant R.V., Heishman S.J., Bunker E.B., and Pickworth W.B. Acute and residual effects of marijuana in humans. Pharmacol Biochem Behav 60 (1998) 777-784
5. Fisher B.A., Ghuran A., Vadamalai V., and Antonios T.F. Cardiovascular complications induced by cannabis smoking: a case report and review of the literature. Emerg Med J 22 (2005) 679-680
6. Ghuran A., and Nolan J. Recreational drug misuse: issues for the cardiologist. Heart 83 (2000) 627-633
7. Ghuran A., Der Wieken L.R., and Nolan J. Cardiovascular complications of recreational drugs. BMJ 323 (2001) 464-466
8. Akins D., and Awdeh M.R. Marijuana and second-degree AV block. South Med J 74 (1981) 371-373
9. Singh G.K. Atrial fibrillation associated with marijuana use. Pediatr Cardiol 21 (2000) 284
10. Kosior D.A., Filipiak K.J., Stolarz P., and Opolski G. Paroxysmal atrial fibrillation in a young female patient following marijuana intoxication-a case report of possible association. Med Sci Monit 6 (2000) 386-389
11. Kosior D.A., Filipiak K.J., Stolarz P., and Opolski G. Paroxysmal atrial fibrillation following marijuana intoxication: a two-case report of possible association. Int J Cardiol 78 (2001) 183-184
12. Mittleman M.A., Lewis R.A., Maclure M., Sherwood J.B., and Muller J.E. Triggering myocardial infarction by marijuana. Circulation 103 (2001) 2805-2809
13. Collins J.S., Higginson J.D., Boyle D.M., and Webb S.W. Myocardial infarction during marijuana smoking in a young female. Eur Heart J 6 (1985) 637-638
14. MacInnes D.C., and Miller K.M. Fatal coronary artery thrombosis associated with cannabis smoking. J R Coll Gen Pract 34 (1984) 575-576
15. Charles R., Holt S., and Kirkham N. Myocardial infarction and marijuana. Clin Toxicol 14 (1979) 433-438
16. Bachs L., and Morland H. Acute cardiovascular fatalities following cannabis use. Forensic Sci Int 124 (2001) 200-203
17. Randall M.D., Kendall D.A., and O'Sullivan S. The complexities of the cardiovascular actions of cannabinoids. Br J Pharmacol 142 (2004) 20-26
18. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., and Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346 (1990) 561-564
19. Munro S., Thomas K.L., and Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365 (1993) 61-65
20. Galiegue S., Mary S., Marchand J., et al. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232 (1995) 54-61
21. Huestis M.A., Gorelick D.A., Heishman S.J., et al. Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch Gen Psychiatry 58 (2001) 322-328
22. Jones R.T. Cardiovascular system effects of marijuana. J Clin Pharmacol 42 (2002) 58S-63S
23. Bramness J.G., Skurtveit S., and Morland J. Clinical impairment of benzodiazepines-relation between benzodiazepine concentrations and impairment in apprehended drivers. Drug Alcohol Depend 68 (2002) 131-141
24. Khiabani H.Z., Bramness J.G., Bjorneboe A., and Morland J. Relationship between THC concentration in blood and impairment in apprehended drivers. Traffic Inj Prev 7 (2006) 111-116
25. Bramness J.G., Skurtveit S., and Morland J. Testing for benzodiazepine inebriation-relationship between benzodiazepine concentration and simple clinical tests for impairment in a sample of drugged drivers. Eur J Clin Pharmacol 59 (2003) 593-601
26. Christophersen A.S., Gjerde H., Bjorneboe A., Sakshaug J., and Morland J. Screening for drug use among Norwegian drivers suspected of driving under influence of alcohol or drugs. Forensic Sci Int 45 (1990) 5-14
27. Cocchetto D.M., Owens S.M., Perez-Reyes M., DiGuiseppi S., and Miller L.L. Relationship between plasma delta-9-tetrahydrocannabinol concentration and pharmacologic effects in man. Psychopharmacology (Berl ) 75 (1981) 158-164
28. Singh G.K. Atrial fibrillation associated with marijuana use. Pediatr Cardiol 21 (2000) 284
29. Fisher B.A., Ghuran A., Vadamalai V., and Antonios T.F. Cardiovascular complications induced by cannabis smoking: a case report and review of the literature. Emerg Med J 22 (2005) 679-680
30. Newlin D.B., Wong C.J., Stapleton J.M., and London E.D. Intravenous cocaine decreases cardiac vagal tone, vagal index (derived in lorenz space), and heart period complexity (approximate entropy) in cocaine abusers. Neuropsychopharmacology 23 (2000) 560-568
31. Ishac E.J., Jiang L., Lake K.D., Varga K., Abood M.E., and Kunos G. Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br J Pharmacol 118 (1996) 2023-2028